Delivery Order SPE2DB24D2215-SPE2DB26FGRXH
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of 1,000 tablets of Metoprolol Succinate Extended Release 50 mg, with a contract ceiling value of $4,081.00 and completion deadline of September 11, 2025. This is a firm fixed-price delivery order issued without set-aside restrictions, meaning it was competitively awarded. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains...
- The Defense Logistics Agency awarded a delivery order valued at $4,155.00 to AmerisourceBergen Drug Corp for 1,000 tablets of Metoprolol Succinate Extended-Release 50 mg, with an ultimate completion date of July 28, 2025. This non-set-aside, firm fixed-price contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement valued through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Metoprolol Succinate Extended Release 25 mg tablets in quantities of 1,000 units. This firm fixed-price delivery order, valued at $1,542.30, represents a non-competitive set-aside contract and is scheduled for completion by August 28, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at...
- The Defense Logistics Agency awarded a $2,922.58 delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of 1,000 tablets of Metoprolol Succinate ER 25 mg, with performance to be completed by September 26, 2025. The contract was awarded on a firm fixed-price basis without set-aside designation, reflecting open competition among qualified vendors. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Metoprolol Succinate Extended Release 50 mg tablets (100-count bottles) with a ceiling value of $1,239.66. This firm fixed-price delivery order is scheduled for ultimate completion by September 29, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Metoprolol Succinate Extended Release 50 mg tablets (1,000 count) with a ceiling value of $1,698.57. This firm fixed price delivery order, awarded on August 12, 2025, represents a non-competitive set-aside procurement and is set to be completed by August 13, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Metoprolol Succinate ER 25 mg tablets (1,000 count) under a firm fixed-price contract valued at $3,408.15. The award, issued on April 24, 2025, with an ultimate completion date of April 25, 2025, represents a non-competitive delivery order executed against AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. Performance will be completed at the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 26, 2025, for the supply of Metoprolol Succinate Extended Release 50 mg tablets in a quantity of 1,000 units, with a ceiling value of $1,190.86. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award. The contract is set to be completed by June 27, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- This is a $1,785.84 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for Metoprolol Succinate Extended-Release 25 mg tablets, with an ultimate completion date of June 10, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $1,237.68 firm fixed price delivery order is for the supply of 4,566,307,621 tablets of the cardiovascular medication Metoprolol Succinate Extended Release 100 mg. The contract has a completion date of November 4, 2024. Amerisourcebergen is a major pharmaceutical distributor that provides a wide range of medical products and supplies to...
- SPE2DB24D2215Indefinite Delivery Contract
- SPE2DB24D2215-SPE2DB26FGRXHDelivery Order
The Defense Logistics Agency awarded a $3,454.23 delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of 1,000 tablets of Metoprolol Succinate Extended-Release 50 mg, with completion scheduled for October 17, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this order under its existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as the primary vehicle for pharmaceutical support to military healthcare systems worldwide. This delivery order represents routine pharmaceutical procurement supporting federal medical supply chain operations. AmerisourceBergen's substantial IDC with the Defense Logistics Agency enables the company to supply a comprehensive range of generic and brand-name medications, vaccines, and medical supplies across multiple therapeutic domains to support Defense Health Agency operations and other government healthcare systems. The award demonstrates the contractor's established capability to meet competitive federal procurement requirements and its critical role as a primary pharmaceutical vendor for U.S. military and federal healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 10/16/25 |